CREW Herbalife Ltd. HLF Bill Ackman speaking

Bill Ackman Is Into Pharmaceuticals (Companies)

CNBC’s Kate Kelly has the details on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX)’s bid for Allergan, Inc. (NYSE:AGN), and why Bill Ackman is attracted to pharmaceuticals now.

Bill Ackman Is Into Pharmaceuticals (Companies)

Bill Ackman’s big bet on pharma

Transcript

we’re well into hour number two of this investor presentation when we heard from both. big ackman taking the stage for the second time since i’ve been here just as i walked out. he’ll be taking q&a in just a few minutes. a quick reminder on what this deal entails. it’s essentially a proposes cash and stock transaction in which every share of allergan would be received for cash as well as a large majority of a valeant shares, a lot of talk from michael pearson today who’s been successful in dlirg shareholder returns about the durability of his assets, the products, the fact there’s less of a patent cliff that this there is for many other similar companies. the emphasis on sales as opposed to more traditional areas like r & d. then we heard from big ackman. he made interesting points about why he stayed away from pharmaceuticals in the past, but why this deal was attractive to him. let’s take a quick listen. in pharmaceuticals before. why is that? because the typical pharmaceutical business, you have products constantly coming off patent, investing huge amounts of money on speculative r&d. price pressure, but then i learned about valeant. what we like is it fits our paradigm. a business with durable products and brands. the persistent cash flow we look for. reporter: so a lot of attractive points for bill ackman. he’s betting very big on this. 30% tied up in the combination of his investment in valeant, allergan.

LEAVE A COMMENT


Saved Articles
X
TextTExtLInkTextTExtLInk

The Life and Career of Charlie Munger

Charlie is more than just Warren Buffett’s friend and Berkshire Hathaway’s Vice Chairman – Buffett has actually credited him with redefining how he looks at investing. Now you can learn from Charlie firsthand via this incredible ebook and over a dozen other famous investor studies by signing up below:

  • Learn from the best and forever change your investing perspective
  • One incredible tidbit of knowledge after another in the page-turning masterpiece of a book
  • Discover the secrets to Charlie’s success and how to apply it to your investing
Never Miss A Story!
Subscribe to ValueWalk Newsletter. We respect your privacy.

Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Welcome in the new year by signing up up for ValueWalkPremium today and get our exclusive content for 40% off. This is our second biggest discount ever!!

Use coupon code VIP20 or click on the button below

Limited time offer only ENDS 1/31/2019 or after next 30 23 subscribers take advantage whichever comes first – please do not share this discount with others

 

0